Patent · US Active

Hydrogen sulphide compounds

US10821122B2 · kind B2 · utility

0Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2018
Grant dateNov 3, 2020
Priority date
Expiry dateDec 21, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The application describes Hydrogen Sulphide (H2S), or a (H2S) generating compound or compound capable of stimulating H2S production in a pregnant subject, for use in the treatment of pre-eclampsia (PE) or fetal growth restriction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.